AAAAAA
Results:
1-23
|
Results: 23
Authors:
Nieder, C
Petersen, S
Petersen, C
Thames, HD
Citation: C. Nieder et al., The challenge of p53 as prognostic and predictive factor in Hodgkin's or non-Hodgkin's lymphoma, ANN HEMATOL, 80(1), 2001, pp. 2-8
Cervical lymph node metastases from occult squamous cell carcinoma: Cut down a tree to get an apple?
Authors:
Nieder, C
Gregoire, V
Ang, KK
Citation: C. Nieder et al., Cervical lymph node metastases from occult squamous cell carcinoma: Cut down a tree to get an apple?, INT J RAD O, 50(3), 2001, pp. 727-733
Authors:
Nestle, U
Nieder, C
Abel, U
Citation: U. Nestle et al., A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60 Gy: Results of a randomized equivalence study: Regarding Nestle et al. IJROBP 2000;48 : 95-103 - In response to Drs. Byhardt and Scott, INT J RAD O, 50(3), 2001, pp. 837-837
Authors:
Grosu, AL
Feldmann, HJ
Stark, S
Pinsker, M
Nieder, C
Kneschaurek, P
Lumenta, C
Molls, M
Citation: Al. Grosu et al., Stereotactic radiotherapy using linear accelerator in patients with brain metastases, NERVENARZT, 72(10), 2001, pp. 770-781
Authors:
Petersen, S
Thames, HD
Nieder, C
Petersen, C
Baumann, M
Citation: S. Petersen et al., The results of colorectal cancer treatment by p53 status - Treatment-specific overview, DIS COL REC, 44(3), 2001, pp. 322-333
Authors:
Nieder, C
Milas, L
Ang, KK
Citation: C. Nieder et al., Tissue tolerance to reirradiation, SEM RAD ONC, 10(3), 2000, pp. 200-209
Authors:
Nestle, U
Nieder, C
Walter, K
Abel, U
Ukena, D
Sybrecht, GW
Schnabel, K
Citation: U. Nestle et al., A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60 GY: Results of a randomized equivalence study, INT J RAD O, 48(1), 2000, pp. 95-103
Authors:
Nieder, C
Citation: C. Nieder, Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases: Regarding Kondziolka et al. IJROBP 1999;45 : 427-434, INT J RAD O, 46(4), 2000, pp. 1081-1081
Authors:
Nieder, C
Nestle, U
Motaref, B
Walter, K
Niewald, M
Schnabel, K
Citation: C. Nieder et al., Prognostic factors in brain metastases: Should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?, INT J RAD O, 46(2), 2000, pp. 297-302
Authors:
Nieder, C
Grosu, AL
Molls, M
Citation: C. Nieder et al., A comparison of treatment results for recurrent malignant gliomas, CANC TR REV, 26(6), 2000, pp. 397-409
Authors:
Nieder, C
Petersen, S
Petersen, C
Thames, HD
Citation: C. Nieder et al., The challenge of p53 as prognostic and predictive factor in gliomas, CANC TR REV, 26(1), 2000, pp. 67-73
Authors:
Nieder, C
Nestle, U
Walter, K
Niewald, M
Schnabel, K
Citation: C. Nieder et al., Dose-response relationships for radiotherapy of brain metastases - Role ofintermediate-dose stereotactic radiosurgery plus whole-brain radiotherapy, AM J CL ONC, 23(6), 2000, pp. 584-588
Authors:
Nieder, C
Nestle, U
Citation: C. Nieder et U. Nestle, A review of current and future treatment strategies for malignant astrocytomas in adults, STRAH ONKOL, 176(6), 2000, pp. 251-258
Authors:
Nieder, C
Ataman, F
Price, RE
Ang, KK
Citation: C. Nieder et al., Radiation myelopathy: New perspective on an old problem, RADIAT ON I, 7(4), 1999, pp. 193-203
Authors:
Nieder, C
Nestle, U
Ketter, R
Kolles, H
Gentner, SJ
Steudel, WI
Schnabel, K
Citation: C. Nieder et al., Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblastoma multiforme, RADIAT ON I, 7(1), 1999, pp. 36-41
Authors:
Nestle, U
Walter, K
Schmidt, S
Licht, N
Nieder, C
Motaref, B
Hellwig, D
Niewald, M
Ukena, D
Kirsch, CM
Sybrecht, GW
Schnabel, K
Citation: U. Nestle et al., F-18-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: High impact in patients with atelectasis, INT J RAD O, 44(3), 1999, pp. 593-597
Authors:
Nieder, C
Citation: C. Nieder, Regarding prognostic factors derived from recursive partition analysis (RPA) of radiation therapy oncology group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases: Agboola etal, IJROBP 42 : 155-159,1998, INT J RAD O, 43(5), 1999, pp. 1170-1171
Authors:
Nieder, C
Leicht, A
Motaref, B
Nestle, U
Niewald, M
Schnabel, K
Citation: C. Nieder et al., Late radiation toxicity after whole-brain radiotherapy - The influence of antiepileptic drugs, AM J CL ONC, 22(6), 1999, pp. 573-579
Authors:
Nieder, C
Ataman, F
Price, RE
Ang, KK
Citation: C. Nieder et al., Biological prevention and/or treatment strategies for radiation myelopathy. Discussion of a new perspective, STRAH ONKOL, 175(9), 1999, pp. 437-443
Authors:
Nieder, C
Citation: C. Nieder, Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma - A prospective study, CANCER, 86(5), 1999, pp. 900-902
Authors:
Nieder, C
Citation: C. Nieder, Stereotactic radiosurgery for brain metastasis from renal cell carcinoma, CANCER, 85(1), 1999, pp. 251-252
Authors:
Nieder, C
Citation: C. Nieder, Radiotherapy of brain metastases from lung cancer, LUNG CANC, 22(2), 1998, pp. 157-158
Authors:
Nieder, C
Citation: C. Nieder, Comment on: Tumor volume as a response predictor in radiotherapy, RADIOTH ONC, 48(3), 1998, pp. 347-348
Risultati:
1-23
|